139 related articles for article (PubMed ID: 33731274)
1. The Stage at Presentation and Oncologic Outcomes for Agent Orange Exposed and Non-Exposed United States Veterans Diagnosed With Prostate Cancer.
Tward AE; Tward JD
Clin Genitourin Cancer; 2021 Aug; 19(4):369-369.e7. PubMed ID: 33731274
[TBL] [Abstract][Full Text] [Related]
2. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
[TBL] [Abstract][Full Text] [Related]
3. Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy.
Shah SR; Freedland SJ; Aronson WJ; Kane CJ; Presti JC; Amling CL; Terris MK
BJU Int; 2009 May; 103(9):1168-72. PubMed ID: 19298411
[TBL] [Abstract][Full Text] [Related]
4. Agent Orange and long-term outcomes after radical prostatectomy.
Ovadia AE; Terris MK; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ; Abern MR
Urol Oncol; 2015 Jul; 33(7):329.e1-6. PubMed ID: 25998746
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange.
Everly L; Merrick GS; Allen ZA; Butler WM; Wallner K; Lief JH; Galbreath RW; Adamovich E
Brachytherapy; 2009; 8(1):57-62. PubMed ID: 18955017
[TBL] [Abstract][Full Text] [Related]
6. Agent Orange as a risk factor for high-grade prostate cancer.
Ansbaugh N; Shannon J; Mori M; Farris PE; Garzotto M
Cancer; 2013 Jul; 119(13):2399-404. PubMed ID: 23670242
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection in veterans with a history of Agent Orange exposure.
Zafar MB; Terris MK
J Urol; 2001 Jul; 166(1):100-3. PubMed ID: 11435832
[TBL] [Abstract][Full Text] [Related]
8. Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesis.
Shallis RM; Gore SD
Leuk Lymphoma; 2022 Jul; 63(7):1534-1543. PubMed ID: 35105250
[TBL] [Abstract][Full Text] [Related]
9. Exposure to Agent Orange is associated with increased recurrence after surgical treatment of stage I non-small cell lung cancer.
Subramanian MP; Eaton DB; Labilles UL; Heiden BT; Chang SH; Yan Y; Schoen MW; Patel MR; Kreisel D; Nava RG; Thomas TS; Meyers BF; Kozower BD; Puri V
J Thorac Cardiovasc Surg; 2024 May; 167(5):1591-1600.e2. PubMed ID: 37709166
[TBL] [Abstract][Full Text] [Related]
10. Exposure to Agent Orange and Risk of Bladder Cancer Among US Veterans.
Williams SB; Janes JL; Howard LE; Yang R; De Hoedt AM; Baillargeon JG; Kuo YF; Tyler DS; Terris MK; Freedland SJ
JAMA Netw Open; 2023 Jun; 6(6):e2320593. PubMed ID: 37368398
[TBL] [Abstract][Full Text] [Related]
11. Agent Orange exposure and risk of death in Korean Vietnam veterans: Korean Veterans Health Study.
Yi SW; Ryu SY; Ohrr H; Hong JS
Int J Epidemiol; 2014 Dec; 43(6):1825-34. PubMed ID: 25186308
[TBL] [Abstract][Full Text] [Related]
12. The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemia.
Baumann Kreuziger LM; Tarchand G; Morrison VA
Leuk Lymphoma; 2014 Jan; 55(1):63-6. PubMed ID: 23573826
[TBL] [Abstract][Full Text] [Related]
13. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
[TBL] [Abstract][Full Text] [Related]
14. High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy.
Li Q; Lan L; Klaassen Z; Shah SR; Moses KA; Terris MK
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):376-81. PubMed ID: 24018710
[TBL] [Abstract][Full Text] [Related]
15. Agent Orange exposure and disease prevalence in Korean Vietnam veterans: the Korean veterans health study.
Yi SW; Hong JS; Ohrr H; Yi JJ
Environ Res; 2014 Aug; 133():56-65. PubMed ID: 24906069
[TBL] [Abstract][Full Text] [Related]
16. Health status of Army Chemical Corps Vietnam veterans who sprayed defoliant in Vietnam.
Kang HK; Dalager NA; Needham LL; Patterson DG; Lees PS; Yates K; Matanoski GM
Am J Ind Med; 2006 Nov; 49(11):875-84. PubMed ID: 17006952
[TBL] [Abstract][Full Text] [Related]
17. Agent Orange exposure and attributed health effects in Vietnam veterans.
Young AL; Cecil PF
Mil Med; 2011 Jul; 176(7 Suppl):29-34. PubMed ID: 21916327
[TBL] [Abstract][Full Text] [Related]
18. Agent Orange exposure and cancer incidence in Korean Vietnam veterans: a prospective cohort study.
Yi SW; Ohrr H
Cancer; 2014 Dec; 120(23):3699-706. PubMed ID: 25103108
[TBL] [Abstract][Full Text] [Related]
19. Urologic cancer risks for veterans exposed to Agent Orange.
Hoenemeyer LA
Urol Nurs; 2013; 33(2):87-90, 99. PubMed ID: 23734554
[TBL] [Abstract][Full Text] [Related]
20. Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in US Army Vietnam-era veterans. The Centers for Disease Control Veterans Health Studies.
JAMA; 1988 Sep; 260(9):1249-54. PubMed ID: 2841506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
